How does the ASH 2021 data contribute to the roadmap for a cure for newly-diagnosed multiple myeloma?


Learning objective:

After participating in this webinar, viewers should be able to:

  • Evaluate how the data from ASH 2021 informs the clinical management of patients with newly-diagnosed multiple myeloma



  • Michel Delforge (Belgium)
  • Maria-Victoria Mateos (Spain)
  • Mohamad Mohty (France)
  • Rakesh Popat (UK)
  • Niels van de Donk (Netherlands)
  • Roberto Mina (Italy)


More Info
62 Minutes
EM-77809 - Date of preparation: October 2021